idiopathic Parkinson's disease
GPTKB entity
Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
neurodegenerative disease
movement disorder |
| gptkbp:affects |
substantia nigra
|
| gptkbp:alsoKnownAs |
gptkb:Parkinson's_disease
|
| gptkbp:causedBy |
unknown
|
| gptkbp:characterizedBy |
loss of dopaminergic neurons
|
| gptkbp:complication |
gptkb:dementia
gptkb:depression autonomic dysfunction |
| gptkbp:firstDescribed |
gptkb:James_Parkinson
1817 |
| gptkbp:hasDiagnosticMethod |
gptkb:DaTscan
clinical diagnosis |
| gptkbp:hasOrphanetID |
gptkb:Parkinson_disease_(ORPHA:411)
|
| https://www.w3.org/2000/01/rdf-schema#label |
idiopathic Parkinson's disease
|
| gptkbp:ICD-10_code |
gptkb:G20
|
| gptkbp:MeSH_ID |
D010300
|
| gptkbp:OMIM |
168600
|
| gptkbp:prevalence |
1% of people over 60
|
| gptkbp:riskFactor |
age
family history male sex |
| gptkbp:symptom |
bradykinesia
postural instability rigidity tremor |
| gptkbp:treatment |
gptkb:levodopa
MAO-B inhibitors deep brain stimulation dopamine agonists |
| gptkbp:bfsParent |
gptkb:Parkinson's_disease
|
| gptkbp:bfsLayer |
5
|